MeSH term
Frequency | Condition_Probility | Base Sequence | 15 | 0.0 |
DNA Primers | 3 | 0.0 |
Genotype | 2 | 0.0 |
Humans | 75 | 0.0 |
Inhibins/blood | 2 | 22.0 |
Male | 33 | 0.0 |
Receptors, FSH/*genetics | 20 | 86.0 |
Research Support, Non-U.S. Gov't | 46 | 0.0 |
Testosterone/blood | 3 | 0.0 |
Amino Acid Sequence | 18 | 0.0 |
Animals | 42 | 0.0 |
Cell Line | 14 | 0.0 |
Cyclic AMP/metabolism | 8 | 1.0 |
Follicle Stimulating Hormone/metabolism | 2 | 8.0 |
Immunohistochemistry | 2 | 0.0 |
Molecular Sequence Data | 26 | 0.0 |
Mutagenesis, Site-Directed | 3 | 0.0 |
Radioligand Assay | 3 | 0.0 |
Receptors, FSH/*chemistry/genetics/*metabolism | 2 | 100.0 |
Research Support, U.S. Gov't, P.H.S. | 24 | 0.0 |
Transfection | 15 | 0.0 |
*Gene Expression | 5 | 0.0 |
Mice | 13 | 0.0 |
Mice, Transgenic | 3 | 0.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Adult | 13 | 0.0 |
Aged | 3 | 0.0 |
Female | 46 | 0.0 |
Gene Expression Regulation | 5 | 0.0 |
Granulosa Cell Tumor/*genetics/metabolism | 2 | 100.0 |
Middle Aged | 4 | 0.0 |
Ovarian Neoplasms/*genetics/metabolism | 2 | 5.0 |
CHO Cells | 5 | 0.0 |
Follicle Stimulating Hormone/*pharmacology | 4 | 13.0 |
Hamsters | 6 | 0.0 |
Adolescent | 3 | 0.0 |
Amino Acid Substitution | 5 | 0.0 |
Base Sequence/genetics | 2 | 0.0 |
Heterozygote | 2 | 0.0 |
Mutation/*physiology | 2 | 1.0 |
Ovarian Failure, Premature/*genetics | 2 | 13.0 |
Protein Structure, Tertiary/genetics | 2 | 0.0 |
Dimerization | 2 | 0.0 |
Rats | 13 | 0.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Structure-Activity Relationship | 6 | 0.0 |
Tumor Cells, Cultured | 7 | 0.0 |
Gene Expression | 5 | 0.0 |
Pregnancy | 7 | 0.0 |
RNA, Messenger/biosynthesis/genetics | 2 | 0.0 |
Receptors, FSH/*biosynthesis/genetics | 2 | 100.0 |
*Transfection | 3 | 1.0 |
Alleles | 5 | 0.0 |
Case-Control Studies | 2 | 0.0 |
Gene Frequency | 3 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
Pregnancy, Multiple/*genetics | 2 | 66.0 |
Twins, Dizygotic/*genetics | 2 | 12.0 |
*Point Mutation | 4 | 0.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Polymorphism, Single-Stranded Conformational | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
Mutation | 5 | 0.0 |
Promoter Regions (Genetics)/*physiology | 2 | 2.0 |
Follicle Stimulating Hormone, beta Subunit | 2 | 18.0 |
*Mutation | 9 | 0.0 |
Chromosomes, Human, Pair 2 | 2 | 1.0 |
Linkage (Genetics) | 3 | 0.0 |
Pedigree | 4 | 0.0 |
Binding Sites | 4 | 0.0 |
Follicle Stimulating Hormone/*metabolism | 3 | 50.0 |
Recombinant Proteins/metabolism | 3 | 0.0 |
Signal Transduction | 3 | 0.0 |
Cattle | 3 | 0.0 |
Comparative Study | 7 | 0.0 |
Follicle Stimulating Hormone/pharmacology | 5 | 8.0 |
Receptors, FSH/*metabolism | 4 | 66.0 |
Receptors, LH/*metabolism | 3 | 42.0 |
Protein Binding | 5 | 0.0 |
Protein Conformation | 3 | 0.0 |
Sequence Alignment | 4 | 0.0 |
Exons | 2 | 0.0 |
RNA, Messenger/*genetics/metabolism | 2 | 2.0 |
Receptors, FSH/biosynthesis/*genetics | 4 | 100.0 |
Receptors, LH/biosynthesis/*genetics | 2 | 66.0 |
Reverse Transcriptase Polymerase Chain Reaction | 7 | 0.0 |
Sequence Analysis, DNA | 5 | 0.0 |
Cell Membrane/metabolism | 2 | 0.0 |
Cloning, Molecular | 6 | 0.0 |
Kinetics | 3 | 0.0 |
Protein Structure, Secondary | 2 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Sequence Homology, Amino Acid | 6 | 0.0 |
Amino Acid Motifs | 2 | 0.0 |
Cells, Cultured | 3 | 0.0 |
Models, Molecular | 4 | 0.0 |
Receptors, LH/chemistry/*metabolism | 2 | 100.0 |
Ligands | 2 | 0.0 |
Cell Division | 2 | 0.0 |
Receptors, FSH/*biosynthesis | 2 | 100.0 |
Receptors, FSH/*genetics/metabolism | 4 | 100.0 |
Testis/*metabolism | 3 | 3.0 |
Phenotype | 2 | 0.0 |
Receptors, FSH/drug effects/*genetics/metabolism | 2 | 100.0 |
Granulosa Cells/metabolism | 3 | 8.0 |
Receptors, FSH/genetics/*metabolism | 4 | 66.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Recombinant Proteins/pharmacology | 2 | 0.0 |
Tetradecanoylphorbol Acetate/pharmacology | 2 | 0.0 |
COS Cells | 5 | 0.0 |
Finland | 2 | 0.0 |
Time Factors | 2 | 0.0 |
Sheep | 2 | 0.0 |
Swine | 2 | 0.0 |
Receptors, LH/*genetics | 3 | 27.0 |
Embryo | 2 | 0.0 |
Kidney | 2 | 0.0 |
Protein Folding | 3 | 0.0 |
Receptors, FSH/genetics | 2 | 25.0 |
Polymerase Chain Reaction | 5 | 0.0 |
Blotting, Western | 3 | 0.0 |
Infertility, Male/blood | 2 | 50.0 |
Ovarian Hyperstimulation Syndrome/*genetics | 2 | 100.0 |
Recurrence | 2 | 0.0 |
Genomic Library | 2 | 0.0 |
Restriction Mapping | 2 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
RNA, Messenger/*analysis | 3 | 0.0 |
Receptors, FSH/*analysis | 2 | 66.0 |
Genes, Structural | 4 | 0.0 |
Mammals/genetics | 2 | 3.0 |
Phosphorylation | 2 | 0.0 |
Macaca fascicularis | 2 | 0.0 |
RNA Probes | 2 | 1.0 |
Forskolin/pharmacology | 2 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
*Chromosomes, Human, Pair 2 | 2 | 0.0 |
Ovary/metabolism | 2 | 2.0 |
